Recently Completed Research Studies

Below is an archive of some of the research studies we conducted in the Penn Sjögren's Center. All studies on this page are closed to enrollment. For more detailed information about these studies, please look up the given NCT# in clinicaltrials.gov.

TWINSS

Full Name: A 48-week, 6-arm, randomized, double-blind, placebocontrolled multicenter trial to assess the safety and efficacy of multiple CFZ533 doses administered subcutaneously in two distinct populations of patients with Sjögren’s Syndrome (TWINSS)
Study Dates: 2021-2023
NCT #: NCT03905525
Study Findings: Data in analysis phase.

DAHLIAS

Full Name: A Randomized, Placebo-controlled, Double-blind, Multicenter Study to Assess the Efficacy and Safety of Nipocalimab in Adults with Primary Sjogren's Syndrome (pSS)
Study Dates: 2022-2024
NCT #: NCT04968912
Study Findings: Study findings not available at this time as the study is still ongoing.